Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pfister

Showing results (171-180 of 288) with videos related to

Pageof 29
Sort By:
Cancer|March 3, 2015
Treatment-related toxicities in older adults with head and neck cancer: A population-based analysisCaitriona B O'Neill, Shrujal S Baxi, Coral L Atoria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)L A Dunn, M G Fury, H Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert PanelB E Hillner, J N Ingle, J R Berenson, et al.
Head & Neck|May 2, 2009
Predictors of outcome for advanced-stage supraglottic laryngeal cancerIan Ganly, Snehal G Patel, Jeanette Matsuo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2007
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancersNancy Y Lee, William O'Meara, Kelvin Chan, et al.
Oncology (Williston Park, N.Y.)|August 12, 1998
NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer NetworkA Forastiere, H Goepfert, D Goffinet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2018
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)L A Dunn, M G Fury, H Xiao, et al.
Cancer|June 8, 2019
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancerEric J Sherman, Lara A Dunn, Heiko Schöder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinomaS L Wolden, M J Zelefsky, D H Kraus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guidelineChristopher E Desch, Al B Benson, Mark R Somerfield, et al.
Pageof 29

Showing results (171-180 of 288) with videos related to

Sort By:
Pageof 29
Cancer|March 3, 2015
Treatment-related toxicities in older adults with head and neck cancer: A population-based analysisCaitriona B O'Neill, Shrujal S Baxi, Coral L Atoria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)L A Dunn, M G Fury, H Xiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert PanelB E Hillner, J N Ingle, J R Berenson, et al.
Head & Neck|May 2, 2009
Predictors of outcome for advanced-stage supraglottic laryngeal cancerIan Ganly, Snehal G Patel, Jeanette Matsuo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2007
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancersNancy Y Lee, William O'Meara, Kelvin Chan, et al.
Oncology (Williston Park, N.Y.)|August 12, 1998
NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer NetworkA Forastiere, H Goepfert, D Goffinet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2018
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)L A Dunn, M G Fury, H Xiao, et al.
Cancer|June 8, 2019
Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancerEric J Sherman, Lara A Dunn, Heiko Schöder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinomaS L Wolden, M J Zelefsky, D H Kraus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guidelineChristopher E Desch, Al B Benson, Mark R Somerfield, et al.
Pageof 29